EMD Serono appoints Scott Filosi as SVP of managed markets

10 September 2015
merck-serono-big-1

EMD Serono, the US biopharma division of German pharma company Merck KGaA (MRK: DE), has appointed Scott Filosi as senior vice president of managed markets.

He will be responsible for developing and executing managed markets marketing, sales and contracting strategies to ensure market access.

Mr Filosi joins from UCB Pharma (Euronext: UCB) where he was head of US market access and pricing and head of established brands in the USA.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Biotechnology